Black patients in England were less likely than White patients to have breast cancer found through screening and waited longer to begin treatment, according to research highlighted Monday by the University of Surrey, emphasizing the need for improved Black breast cancer care.

The university’s October 26 announcement draws attention to gaps at several points in cancer care. It also reports delays affecting people with a learning disability. The findings describe England’s health system. They are not measurements of care in Utica, New York State or the United States.

This highlights the critical importance of ensuring equitable access to Black breast cancer care within the healthcare system.

For Mohawk Valley readers, the report offers a reason to look closely at a practical issue: getting a screening appointment is one step, but receiving results, further tests and treatment also matters.

What the research measured

The peer-reviewed study in Breast Cancer Research was published September 15, before Monday’s announcement. Researchers studied linked health records for 86,564 adults diagnosed with breast cancer in England from 2009 through 2018.

They compared how cancer was found, the time to diagnosis and the time from diagnosis to treatment. Their statistical models accounted for measured patient characteristics.

Black patients had 29 percent lower adjusted odds of a screening diagnosis than White patients. Their time from diagnosis to treatment was about 10 percent longer. People with a learning disability had an 18 percent longer time to diagnosis and an 8 percent longer time to treatment than people without that disability.

The study also found gaps involving severe mental illness, deprivation and other ethnic groups. It was funded by the charity Breast Cancer Now. The authors reported no competing interests.

What the percentages do, and do not, mean

Surrey’s announcement says Black patients had 37 percent higher odds of an emergency diagnosis. It translates the treatment gap into about five additional days, on average, compared with White patients. For people with a learning disability, one in four waited at least 29 days for a diagnosis, the university reports.

Odds are a statistical comparison. The 29 percent figure does not mean that 29 out of every 100 Black patients missed screening. It describes a difference between groups after the researchers’ adjustments. Likewise, a longer average wait does not mean every person waited longer.

The announcement says patients with overlapping disadvantages sometimes faced greater gaps. Researchers said further work is needed to understand the causes and how to close them.

The records end in 2018. The analysis therefore cannot establish today’s waiting times, measure changes made since then or explain every individual delay. It also cannot show that a particular clinician intentionally treated a patient differently. Those limits matter when applying research to real people.

A separate U.S. picture

American data show breast cancer disparities, too, but the numbers come from different populations and should not be combined with the England results.

The American Cancer Society’s Cancer Facts & Figures 2026 reports five-year relative survival of 84 percent for Black women and 94 percent for White women with invasive breast cancer. The report points to differences in stage at diagnosis and cancer subtypes, while noting lower survival for Black women across most subtypes.

Relative survival compares people with cancer with similar people in the general population. It is a population measure, not a prediction of any one patient’s outcome. A person’s diagnosis, tumor features and treatment require an individual medical assessment.

Race alone does not explain a person’s cancer or determine their future. Nor does a national difference prove that a particular Mohawk Valley provider has the same gap. Local claims would require local evidence.

Screening guidance is for people without symptoms

The U.S. Preventive Services Task Force recommends a mammogram every two years for women ages 40 through 74. That guidance concerns routine screening and is not a complete plan for every person’s medical history.

People with higher-risk conditions, including certain inherited gene changes, previous breast cancer or a history of high-dose chest radiation when young, need guidance suited to their situation. The task force says evidence remains insufficient to determine the balance of benefits and harms of routine screening at age 75 and older.

Other medical organizations may recommend a different schedule. A discussion with a clinician should address personal risk, prior results and the reasons for the recommended timing, rather than relying on a single age rule without context.

The Centers for Disease Control and Prevention explains that screening looks for cancer before symptoms appear. A mammogram is an X-ray of the breast. It can help find cancer earlier, but it cannot prevent cancer or detect every case.

Screening can also lead to a false alarm and more tests. Some cancers found through screening would never have caused health problems. These possible harms belong in an honest conversation alongside the benefits. A callback after a mammogram does not, by itself, establish a cancer diagnosis.

A new change needs its own conversation

Routine screening dates should not be used as a reason to ignore a new symptom. The CDC’s symptom guidance lists warning signs such as a new breast or underarm lump, skin dimpling, unusual nipple discharge, a change in breast size or shape, and breast pain.

These signs can have causes other than cancer. The CDC advises people with symptoms to see a doctor right away. A clinician can decide which examination or diagnostic tests are appropriate. A news report cannot make that decision for an individual reader.

Where Mohawk Valley residents can ask for help

The Cancer Services Program of the Central Region serves Oneida, Herkimer and Madison counties, along with Otsego, Delaware and Schoharie counties. The program’s listed contact is 888-345-0225.

The regional service offers eligible residents screening and diagnostic follow-up through participating providers. Its public information also describes help with enrollment in the Medicaid Cancer Treatment Program for eligible uninsured people diagnosed with certain cancers. Eligibility must be checked; a call does not guarantee that every test or treatment is covered.

The New York State Department of Health also lists 866-442-2262 to connect residents with local screening, diagnostic, treatment and support services. Its Cancer Services Program serves eligible uninsured and underinsured residents.

When calling, explain whether the concern is routine screening, a new symptom or follow-up after an earlier test. Ask what records are needed, who will report the results and whom to contact if the next step is unclear. That information helps turn an available service into a usable path to care.

This report provides general health information, not an individual diagnosis or treatment recommendation. The England findings should not be read as current U.S. or local waiting-time estimates. Featured image: a fictional patient and clinician, not study participants. Both illustrations are AI-generated artwork by OpenAI for the Utica Phoenix.